Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation

BACKGROUND: Approximately 15% of lung cancer patients are diagnosed in early stages. Microscopic proof of disease cannot always be obtained because of comorbidity or reluctance to undergo invasive diagnostic procedures. In the current study, survival data of patients with and without pathology are c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zehentmayr, Franz, Sprenger, Martin, Rettenbacher, Lukas, Wass, Romana, Porsch, Peter, Fastner, Gerd, Pirich, Christian, Studnicka, Michael, Sedlmayer, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360228/
https://www.ncbi.nlm.nih.gov/pubmed/30618120
http://dx.doi.org/10.1111/1759-7714.12966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360228/
https://www.ncbi.nlm.nih.gov/pubmed/30618120
http://dx.doi.org/10.1111/1759-7714.12966

Ejemplares similares